GE to demonstrate at RSNA 2014 ultrasound hardware and software.
GE will demonstrate at RSNA 2014 a versatile portfolio of ultrasound hardware and software.
The vScan with Dual Probe is the first of its kind 2-in-1 probe, GE said, which offers health care providers many uses for pocket ultrasound. It houses two transducers in a single probe which should allow clinicians to see shallow and deep views of the body without changing probes.
Volusion E10 with HDlive technology is GE’s newest system and features a curved matrix electronic 4D probe designed specifically for OB/GYN, the world’s first, according to GE. The system provides 2D and 3D/4D images with increased penetration, GE said.
Invenia ABUS has an acquisition process that uses 3D ultrasound technology to image women with dense breast tissue in approximately 15 minutes with features that conform to a woman’s anatomy, GE said.
Shear Wave elastography is a new tool for the LOGIQ E9 with XDclear Shear Wave elastography and offers an advanced level of diagnostic information to help evaluate tissue stiffness, GE said. The LOGIQ E9 ultrasound system uses a focused burst of acoustic energy from the transducer to generate Shear Waves that produce quantitative measurements and a color coded elastogram. These quantifiable exams provide enhanced benefits as compared with traditional strain elastography, GE said.
Vivid E9 with XDclear was built from the Vivid E9 platform and designed to enhance image quality in 2D, 4D, color, and Doppler. The image clarity improvements can be especially helpful for patients that have been difficult to scan in the past, like obese patients, GE said.
Venue 50 is a portable ultrasound that delivers crisp images quickly with the simplicity of a tablet, GE said. The touch user interface offers easy gel-and-go scanning and is designed for speed, GE said.
FDA Clears Controlled Contrast Delivery Method for Ultrasound Imaging of Fallopian Tubes
September 9th 2024Facilitating natural contrast delivery through an intrauterine catheter, FemChec can be utilized for ultrasound assessment of fallopian tubes and may provide diagnostic confirmation for an emerging non-surgical option for permanent birth control.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
FDA Clears Emerging Cardiovascular Point-of-Care Ultrasound Platform
August 22nd 2024Combining four CAD modules for valvular pathologies with a variety of automated measurements, the AI-enabled AISAP Cardio ultrasound system reportedly facilitates up to a 90 percent accuracy rate in detecting common cardiac conditions.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
FDA Clears AI-Powered Cardiovascular Ultrasound System from Siemens Healthineers
August 13th 2024Offering a variety of AI features for streamlined workflow and enhanced visualization, the Acuson Origin ultrasound system also features the newly FDA-cleared AcuNav Lumos 4D ICE (intracardiac echocardiography) catheter.